Jim Cramer on Sarepta Therapeutics: “If it Goes Up, You Gotta Do Some Selling”

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is one of the stocks Jim Cramer talked about. A caller asked for Cramer’s outlook on the stock, and he commented:

“Oh God. I was hoping it’s not Sarepta. I don’t have a positive outlook on Sarepta. I think that they kind of were… What they’re doing is so important, but I don’t think that they have the horses to become more than what they’ve already become. So I think that if it goes up, you gotta do some selling. I’m very sorry.”

A technical stock market chart. Photo by Energepic from Pexels

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) develops genetic medicines, including RNA-targeted therapies and gene therapies for rare diseases. The company’s portfolio includes approved treatments for Duchenne muscular dystrophy and pipeline programs for additional genetic disorders. In a July episode of Squawk on the Street, Cramer discussed the company and said:

“[On firm announcing to not comply with the FDA request to stop shipping] Okay, if RFK Jr. agrees with that I guess they don’t need to. I mean this is part of the new government. And the new government, some people would say, is not in keeping what keeping the government of Hamilton and Jefferson, the founding fathers. And I would come back and say, they too have become irrelevant right now. They could be relevant later on but I’m not auditioning for the show of Hamilton here…

…Look they should be prosecuted if they go after them. Because they kill people. And historically, the FDA is a very good institution. . .our FDA’s the best in the world. They may think it’s not, I know it is. . .And that’s it. You know if you kill people with the trial, that drug is stopped. And last I looked, I would prosecute anyone, any company uses that, I would prosecute the CEO for homicide. Why don’t you just say, listen, I’m going against a charge of homicide because you’re killing people with that. The FDA wants to prove, this is a horrible disease, and the FDA would like, wanted, when this was approved to say, alright, we’ll do anything, these people have nothing. There’s no hope. So we’ll do this. But you can’t kill people on a trial. That’s the FDA’s rule. It’s not like Jim Cramer says, that’s the history of the FDA!”

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.